DrugPatentWatch Database Preview

Cumberland Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for CUMBERLAND PHARMS, and what generic alternatives to CUMBERLAND PHARMS drugs are available?

CUMBERLAND PHARMS has six approved drugs.

There are twenty-seven US patents protecting CUMBERLAND PHARMS drugs.

There are two hundred and seven patent family members on CUMBERLAND PHARMS drugs in forty countries and thirteen supplementary protection certificates in twelve countries.

Summary for Cumberland Pharms

International Patents:	207
US Patents:	27
Tradenames:	7
Ingredients:	6
NDAs:	6

Drugs and US Patents for Cumberland Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cumberland Pharms	VIBATIV	telavancin hydrochloride	POWDER;INTRAVENOUS	022110-002	Sep 11, 2009		RX	Yes	Yes	7,208,471		Y	Y
Cumberland Pharms	VIBATIV	telavancin hydrochloride	POWDER;INTRAVENOUS	022110-002	Sep 11, 2009		RX	Yes	Yes	7,351,691		Y	Y
Cumberland Pharms	VIBATIV	telavancin hydrochloride	POWDER;INTRAVENOUS	022110-001	Sep 11, 2009		DISCN	Yes	No	6,635,618		Y	Y
Cumberland Pharms	ACETADOTE	acetylcysteine	INJECTABLE;INTRAVENOUS	021539-001	Jan 23, 2004	AP	RX	Yes	Yes	9,327,028
Cumberland Pharms	CALDOLOR	ibuprofen	SOLUTION;INTRAVENOUS	022348-002	Jun 11, 2009		RX	Yes	Yes	9,649,284
Cumberland Pharms	VIBATIV	telavancin hydrochloride	POWDER;INTRAVENOUS	022110-001	Sep 11, 2009		DISCN	Yes	No	7,008,923
Cumberland Pharms	VIBATIV	telavancin hydrochloride	POWDER;INTRAVENOUS	022110-001	Sep 11, 2009		DISCN	Yes	No	6,858,584		Y

Paragraph IV (Patent) Challenges for CUMBERLAND PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Injection	200 mg/mL, 30 mL vials		2012-04-04

International Patents for Cumberland Pharms Drugs

Country	Patent Number	Estimated Expiration
Spain	2400483
Brazil	PI1006222
European Patent Office	2495251
Brazil	0110530
Slovenia	1292612
Japan	2004501161
World Intellectual Property Organization (WIPO)	0198329

Supplementary Protection Certificates for Cumberland Pharms Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1292612	2011C/045	Belgium		PRODUCT NAME: VIBATIV - TELAVANCINE; AUTHORISATION NUMBER AND DATE: EU/1/11/705-001 20110902
1292612	PA2012002,C1292612	Lithuania		PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902
1292612	CA 2011 00033	Denmark		PRODUCT NAME: TELAVANCIN, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER TELAVANCIN HYDROCHLORID
1292612	PA2012002	Lithuania		PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902
1292612	36/2011	Austria		PRODUCT NAME: TELAVANCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ HIEVON, EINSCHLIESSLICH TELAVANCINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902
1292612	122011100062	Germany		PRODUCT NAME: TELAVANCIN ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ HIERVON, EINSCHLIESSLICH TELAVANCINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902
1292612	417	Finland

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Cumberland Pharms
• Cumberland Swan